Latest investment marks key milestone in the company’s global growth strategy, supporting clients across an increasingly ...

Accelerating platform-driven clinical innovation across vascular, neurovascular, and cardiovascular applications through a ...

ESTERO, FL / ACCESS Newswire / February 5, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), ...

Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug developmentAMSTERDAM & BOSTON--(BUSINESS WIRE)--VectoryY Therapeutics, a leader ...

SAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed ...

Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year LOS GATOS, ...

DUBLIN, IE / ACCESS Newswire / February 5, 2026 / Ayrmid, Ltd. ("Ayrmid" or the "Company"), the parent company of Gamida Cell Inc., today announced that it has entered into an exclusive distribution ...

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on ...

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new ...

Omisirge transplantation shows accelerated immune recovery in SAANew data presented at the 2026 TANDEM Meetings demonstrate that patients with SAA who received Omisirge experienced faster and more ...